دورية أكاديمية

H1N1 influenza virus infection results in adverse pregnancy outcomes by disrupting tissue-specific hormonal regulation.

التفاصيل البيبلوغرافية
العنوان: H1N1 influenza virus infection results in adverse pregnancy outcomes by disrupting tissue-specific hormonal regulation.
المؤلفون: Littauer EQ; Department of Microbiology & Immunology and Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, United States of America., Esser ES; Department of Microbiology & Immunology and Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, United States of America., Antao OQ; Department of Microbiology & Immunology and Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, United States of America., Vassilieva EV; Department of Microbiology & Immunology and Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, United States of America., Compans RW; Department of Microbiology & Immunology and Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, United States of America., Skountzou I; Department of Microbiology & Immunology and Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, United States of America.
المصدر: PLoS pathogens [PLoS Pathog] 2017 Nov 27; Vol. 13 (11), pp. e1006757. Date of Electronic Publication: 2017 Nov 27 (Print Publication: 2017).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE
أسماء مطبوعة: Original Publication: San Francisco, CA : Public Library of Science, c2005-
مواضيع طبية MeSH: Hormones/*metabolism , Influenza A Virus, H1N1 Subtype/*physiology , Influenza, Human/*physiopathology , Pregnancy Complications/*physiopathology, Animals ; Dinoprostone/metabolism ; Female ; Humans ; Influenza, Human/metabolism ; Influenza, Human/mortality ; Influenza, Human/virology ; Lung/metabolism ; Lung/virology ; Male ; Mice ; Mice, Inbred BALB C ; Organ Specificity ; Placenta/metabolism ; Placenta/virology ; Pregnancy ; Pregnancy Complications/metabolism ; Pregnancy Complications/mortality ; Pregnancy Complications/virology ; Pregnancy Outcome ; Progesterone/metabolism
مستخلص: Increased susceptibility to influenza virus infection during pregnancy has been attributed to immunological changes occurring before and during gestation in order to "tolerate" the developing fetus. These systemic changes are most often characterized by a suppression of cell-mediated immunity and elevation of humoral immune responses referred to as the Th1-Th2 shift. However, the underlying mechanisms which increase pregnant mothers' risk following influenza virus infection have not been fully elucidated. We used pregnant BALB/c mice during mid- to late gestation to determine the impact of a sub-lethal infection with A/Brisbane/59/07 H1N1 seasonal influenza virus on completion of gestation. Maternal and fetal health status was closely monitored and compared to infected non-pregnant mice. Severity of infection during pregnancy was correlated with premature rupture of amniotic membranes (PROM), fetal survival and body weight at birth, lung viral load and degree of systemic and tissue inflammation mediated by innate and adaptive immune responses. Here we report that influenza virus infection resulted in dysregulation of inflammatory responses that led to pre-term labor, impairment of fetal growth, increased fetal mortality and maternal morbidity. We observed significant compartment-specific immune responses correlated with changes in hormonal synthesis and regulation. Dysregulation of progesterone, COX-2, PGE2 and PGF2α expression in infected pregnant mice was accompanied by significant remodeling of placental architecture and upregulation of MMP-9 early after infection. Collectively these findings demonstrate the potential of a seasonal influenza virus to initiate a powerful pro-abortive mechanism with adverse outcomes in fetal health.
References: Am J Pathol. 2014 Sep;184(9):2549-59. (PMID: 25065683)
Front Psychiatry. 2011 Nov 23;2:63. (PMID: 22131978)
Biol Sex Differ. 2010 Nov 04;1(1):5. (PMID: 21208468)
Immunol Res. 2012 Dec;54(1-3):254-61. (PMID: 22447351)
Hum Vaccin. 2011 Jan-Feb;7 Suppl:217-25. (PMID: 21922688)
J Immunol. 2007 May 1;178(9):5949-56. (PMID: 17442979)
Antiviral Res. 2011 Sep;91(3):330-4. (PMID: 21798291)
J Reprod Immunol. 2015 Apr;108:65-71. (PMID: 25817465)
Am J Reprod Immunol. 2012 Sep;68(3):226-32. (PMID: 22762384)
Mol Endocrinol. 2006 Nov;20(11):2724-33. (PMID: 16772530)
PLoS One. 2012;7(4):e35538. (PMID: 22514749)
Viral Immunol. 2012 Oct;25(5):402-10. (PMID: 22985287)
Indian J Endocrinol Metab. 2013 Jan;17(1):50-9. (PMID: 23776853)
Influenza Other Respir Viruses. 2013 Nov;7(6):1033-9. (PMID: 23170853)
PLoS One. 2015 Dec 29;10(12):e0145366. (PMID: 26713439)
Virol J. 2011 Jul 08;8:342. (PMID: 21740553)
Cell Adh Migr. 2016 Mar 3;10 (1-2):136-46. (PMID: 26745344)
Hum Reprod Update. 2003 Nov-Dec;9(6):531-9. (PMID: 14714590)
Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8609-11. (PMID: 12861081)
Am J Obstet Gynecol. 2012 Sep;207(3 Suppl):S3-8. (PMID: 22920056)
Hum Vaccin Immunother. 2012 Jan;8(1):130-7. (PMID: 22251998)
PLoS One. 2013;8(1):e54125. (PMID: 23326583)
Biochem Pharmacol. 2014 Jun 1;89(3):370-85. (PMID: 24704473)
Science. 2016 Feb 26;351(6276):933-9. (PMID: 26822608)
Matern Child Health J. 2013 Sep;17(7):1325-31. (PMID: 23001819)
MMWR Morb Mortal Wkly Rep. 2010 Aug 27;59(33):1057-62. (PMID: 20798667)
Psychol Med. 2013 Feb;43(2):239-57. (PMID: 22717193)
PLoS Pathog. 2016 Sep 15;12 (9):e1005840. (PMID: 27631986)
Obstet Gynecol. 2006 Jun;107(6):1315-22. (PMID: 16738158)
J Reprod Immunol. 2009 Jun;80(1-2):91-9. (PMID: 19371956)
Nat Immunol. 2015 Apr;16(4):328-34. (PMID: 25789673)
Sci Transl Med. 2015 Sep 9;7(304):304ra141. (PMID: 26355030)
Am J Reprod Immunol. 2007 Sep;58(3):268-79. (PMID: 17681043)
Respir Res. 2007 Oct 25;8:73. (PMID: 17961210)
Int J Womens Health. 2014 Jul 25;6:681-9. (PMID: 25114593)
PLoS One. 2012;7(11):e50167. (PMID: 23209664)
Turk J Pediatr. 2011 Jul-Aug;53(4):441-4. (PMID: 21980848)
Cell Host Microbe. 2017 Mar 8;21(3):321-333. (PMID: 28279344)
PLoS One. 2010 Oct 29;5(10):e13757. (PMID: 21060798)
Eur J Immunol. 2004 Nov;34(11):2986-95. (PMID: 15384042)
J Cell Sci. 2014 Jul 15;127(Pt 14):3141-8. (PMID: 24829150)
J Womens Health (Larchmt). 2006 Oct;15(8):891-3. (PMID: 17087611)
Pediatr Infect Dis J. 2016 Oct;35(10 ):1097-103. (PMID: 27314823)
Nature. 1977 Dec 8;270(5637):530-2. (PMID: 593374)
J Clin Virol. 2015 Mar;64:52-8. (PMID: 25728079)
Am J Psychiatry. 2010 Mar;167(3):261-80. (PMID: 20123911)
J Control Release. 2016 Aug 28;236:47-56. (PMID: 27327766)
Cytokine Growth Factor Rev. 2002 Dec;13(6):455-81. (PMID: 12401480)
J Immunol. 2005 Nov 15;175(10):6878-84. (PMID: 16272346)
J Virol. 2014 May;88(9):4711-20. (PMID: 24522912)
J Cell Physiol. 2016 Dec;231(12 ):2599-621. (PMID: 27187048)
Front Pediatr. 2016 Nov 30;4:130. (PMID: 27965950)
J Reprod Immunol. 1996 Aug;31(1-2):81-95. (PMID: 8887124)
JAMA. 2010 Apr 21;303(15):1517-25. (PMID: 20407061)
Front Immunol. 2015 Jun 04;6:289. (PMID: 26089824)
Nat Nanotechnol. 2011 May;6(5):321-8. (PMID: 21460826)
Immunobiology. 2015 Jan;220(1):1-9. (PMID: 25454812)
Nat Med. 2013 May;19(5):548-56. (PMID: 23652115)
J Leukoc Biol. 2012 Jul;92(1):67-73. (PMID: 22131346)
Emerg Infect Dis. 2006 Nov;12(11):1638-43. (PMID: 17283611)
Proc Natl Acad Sci U S A. 1988 Apr;85(7):2315-9. (PMID: 2451246)
J Virol. 2017 Mar 29;91(8):. (PMID: 28179523)
Am J Reprod Immunol. 2010 Dec;64(6):411-26. (PMID: 20712812)
Infect Dis Obstet Gynecol. 2014;2014:768380. (PMID: 24693211)
J Immunol. 2012 Jan 1;188(1):21-8. (PMID: 22187483)
J Inflamm Res. 2015 Oct 03;8:193-200. (PMID: 26491367)
Am J Reprod Immunol. 1996 Apr;35(4):348-51. (PMID: 8739452)
Lancet. 2007 Sep 29;370(9593):1137-45. (PMID: 17905166)
J Virol. 2011 Nov;85(21):11208-19. (PMID: 21865394)
Clin Vaccine Immunol. 2011 Feb;18(2):305-10. (PMID: 21123524)
J Virol. 2000 Jun;74(11):4999-5005. (PMID: 10799573)
Fetal Pediatr Pathol. 2011;30(5):280-5. (PMID: 21612336)
Breathe (Sheff). 2015 Dec;11(4):297-301. (PMID: 27066123)
Am J Reprod Immunol. 1999 Aug;42(2):71-5. (PMID: 10476687)
J Reprod Immunol. 2013 Mar;97(1):62-73. (PMID: 23432873)
Vaccine. 2015 Sep 11;33(38):4850-7. (PMID: 26238723)
J Pathol. 2016 May;239(1):36-47. (PMID: 27071480)
Biochem Soc Trans. 2013 Jun;41(3):701-9. (PMID: 23697929)
Clin Exp Allergy. 2003 Sep;33(9):1244-51. (PMID: 12956746)
N Engl J Med. 2014 Jun 5;370(23):2211-8. (PMID: 24897084)
J Reprod Fertil. 1999 Nov;117(2):315-24. (PMID: 10690199)
PLoS One. 2012;7(7):e40502. (PMID: 22792357)
Cell Immunol. 1990 Mar;126(1):106-16. (PMID: 2105848)
Reprod Sci. 2014 Dec;21(12):1434-51. (PMID: 24899469)
J Clin Invest. 1996 Nov 1;98(9):1971-8. (PMID: 8903315)
J Infect Chemother. 2015 Apr;21(4):238-46. (PMID: 25708925)
Am J Reprod Immunol. 2010 Aug 1;64(2):77-86. (PMID: 20367622)
Early Hum Dev. 2014 Oct;90(10):657-64. (PMID: 25194834)
CA Cancer J Clin. 2012 Sep-Oct;62(5):309-35. (PMID: 22576456)
J Virol. 2005 May;79(10):6441-8. (PMID: 15858027)
Hong Kong Med J. 2013 Jun;19 Suppl 4:29-35. (PMID: 23775184)
Vaccine. 2006 Aug 28;24(35-36):6110-9. (PMID: 16766095)
Nat Rev Genet. 2001 Jul;2(7):538-48. (PMID: 11433360)
Virology. 2014 Jan 5;448:74-81. (PMID: 24314638)
Horm Behav. 2012 Aug;62(3):263-71. (PMID: 22406114)
Eur J Immunol. 2015 Oct;45(10):2858-72. (PMID: 26249148)
PLoS Pathog. 2011 Jul;7(7):e1002149. (PMID: 21829352)
Trends Immunol. 2009 Nov;30(11):538-46. (PMID: 19699683)
J Reprod Immunol. 2011 Jun;90(1):3-8. (PMID: 21641655)
Thorax. 2003 Jul;58(7):585-8. (PMID: 12832671)
معلومات مُعتمدة: HHSN272201400004C United States AI NIAID NIH HHS
المشرفين على المادة: 0 (Hormones)
4G7DS2Q64Y (Progesterone)
K7Q1JQR04M (Dinoprostone)
تواريخ الأحداث: Date Created: 20171128 Date Completed: 20180109 Latest Revision: 20201214
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC5720832
DOI: 10.1371/journal.ppat.1006757
PMID: 29176767
قاعدة البيانات: MEDLINE
الوصف
تدمد:1553-7374
DOI:10.1371/journal.ppat.1006757